Article info
Original research
Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practices
- Correspondence to Dr Catherine H. Watson, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA; catherine.h.watson{at}duke.edu
Citation
Management of high, moderate, and low penetrance ovarian cancer susceptibility mutations: an assessment of current risk reduction practices
Publication history
- Received April 24, 2020
- Revision received July 30, 2020
- Accepted August 3, 2020
- First published August 23, 2020.
Article Versions
- You are currently viewing a Previous version of this article (23 August 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.